Evidence map›Paper›PMID 23536080›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2013

A novel growth-promoting pathway formed by GDNF-overexpressing Schwann cells promotes propriospinal axonal regeneration, synapse formation, and partial recovery of function after spinal cord injury.

Ling-Xiao Deng, Ping Deng, Yiwen Ruan, Zao Cheng Xu, Nai-Kui Liu, Xuejun Wen, George M Smith, Xiao-Ming Xu

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
6.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 121 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Single Nuclei Analyses Reveal Transcriptional Profiles and Marker Genes for Diverse Supraspinal Populations.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Ling-Xiao DengSpinal Cord and Brain Injury Research Group, Stark Neurosciences Research Institute, and Department of Neurological Surgery, Goodman and Campbell Brain and Spine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Ping Deng
Yiwen Ruan
Zao Cheng Xu
Nai-Kui Liu
Xuejun Wen
George M Smith
Xiao-Ming Xu
Allen Institute for Brain Science · USIndiana University – Purdue University Indianapolis · USIndiana University School of MedicineNeurological Surgery · USShriners Hospitals for Children - Philadelphia · USVirginia Commonwealth University · US

Funding

Reprogramming reactive glial cells into functional new neurons after SCIR01NS111776 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI WU, WEI, ZHANG, CHUN-LI · 2020 to 2024
$2.4M
SCHWANN CELLS, NEUROTROPHINS AND SPINAL CORD REGROWTHR01NS036350 · NINDS · UNIVERSITY OF LOUISVILLE · PI XU, XIAO-MING · 1998 to 2006
$1.9M
PKC inhibition-mediated spinal cord regenerationR01NS052290 · NINDS · UNIVERSITY OF LOUISVILLE · PI XU, XIAO-MING · 2005 to 2009
$1.8M
Tissue engineering in spinal cord regenerationR01NS050243 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI WEN, XUEJUN · 2007 to 2011
$1.7M
Role of phospholipase A2 in spinal cord secondary injuryR01NS059622 · NINDS · INDIANA UNIVERSITY INDIANAPOLIS · PI XU, XIAO-MING · 2009 to 2013
$1.6M
NINDS NIH HHS NS036350NINDS NIH HHS NS050243NINDS NIH HHS NS052290NINDS NIH HHS NS059622NINDS NIH HHS R01 NS036350NINDS NIH HHS R01 NS050243NINDS NIH HHS R01 NS052290NINDS NIH HHS R01 NS059622NINDS NIH HHS R01 NS111776
6 · The paper itself

Abstract

Descending propriospinal neurons (DPSN) are known to establish functional relays for supraspinal signals, and they display a greater growth response after injury than do the long projecting axons. However, their regenerative response is still deficient due to their failure to depart from growth supportive cellular transplants back into the host spinal cord, which contains numerous impediments to axon growth. Here we report the construction of a continuous growth-promoting pathway in adult rats, formed by grafted Schwann cells overexpressing glial cell line-derived neurotrophic factor (GDNF). We demonstrate that such a growth-promoting pathway, extending from the axonal cut ends to the site of innervation in the distal spinal cord, promoted regeneration of DPSN axons through and beyond the lesion gap of a spinal cord hemisection. Within the distal host spinal cord, regenerated DPSN axons formed synapses with host neurons leading to the restoration of action potentials and partial recovery of function.

Indexed as

AnimalsBiotinCell CountDextransDisease Models, AnimalElectric StimulationEvoked PotentialsFemaleFunctional LateralityGlial Cell Line-Derived Neurotrophic FactorGlial Fibrillary Acidic ProteinGreen Fluorescent ProteinsGuided Tissue Regeneration, PeriodontalIn Vitro TechniquesMicroscopy, Electron, TransmissionMicrotubule-Associated Proteins2-hydroxy-4,4'-diamidinostilbene, methanesulfonate saltBiotinbiotinylated dextran amineDextransGlial Cell Line-Derived Neurotrophic FactorGlial Fibrillary Acidic ProteinGreen Fluorescent ProteinsMAP2 protein, ratMicrotubule-Associated ProteinsMyelin P0 ProteinStilbamidinesSynaptophysinSyp protein, rat

Identifiers

PMID23536080
PMCPMC3664932
OpenAlexW2048719143

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.